Welcome to our dedicated page for Optex Systems SEC filings (Ticker: OPXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Optex Systems Holdings, Inc. (NASDAQ: OPXS) SEC filings page provides access to the company’s regulatory disclosures as a publicly traded manufacturer of optical sighting systems and assemblies. Optex operates in the optical instrument and lens manufacturing sector and focuses primarily on Department of Defense applications, with products installed on U.S. military land vehicles such as Abrams and Bradley fighting vehicles, Light Armored and Armored Security Vehicles, and selected Stryker vehicles.
Through its filings with the U.S. Securities and Exchange Commission, Optex reports information on its financial condition, operating performance, and corporate governance. Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q, referenced in the company’s earnings press releases, include GAAP financial statements, discussions of revenue, gross profit, operating income, net income, working capital, and backlog, as well as explanations of non-GAAP measures such as Adjusted EBITDA.
Current Reports on Form 8-K document material events affecting OPXS, such as the release of quarterly and annual financial results, participation in investor conferences, amendments to bylaws, and executive leadership changes. For example, 8-K filings have covered the appointment of a new President, the creation of a Chief Executive Officer position in the bylaws, and the furnishing of earnings press releases for fiscal periods.
On this page, users can review real-time updates from EDGAR, including 10-K and 10-Q reports for detailed financial and operational disclosures, as well as 8-K filings for timely event-driven information. AI-powered summaries help explain the content and implications of lengthy filings, highlight key metrics, and make complex regulatory language more accessible, while still directing readers to the original documents for full context.
Investors researching OPXS can use this filings archive to examine Optex’s reporting history, understand changes in its governance framework, and follow how the company communicates about its defense optics manufacturing operations, financial performance, and corporate actions over time.
Schedule 13G/A filing overview: Galileo Partners, LLC submitted Amendment No. 1 to Schedule 13G reporting its beneficial ownership in Optex Systems Holdings, Inc. (OPXS) common stock. The filing relates to an ownership position as of June 23 2025.
Key ownership details
- Shares beneficially owned: 330,000
- Percent of class: 4.8% (below the 5 % threshold that defines a “5 % holder” under Section 13(d))
- Sole voting power: 330,000 shares
- Sole dispositive power: 330,000 shares
- Shared voting/dispositive power: 0 shares
The reporting person is organized in Delaware and classifies itself as “PN” (private partnership/limited liability company). Because Item 5 indicates “Ownership of 5 percent or less of a class,” this amendment places Galileo Partners below the statutory large-shareholder threshold, signalling it is no longer a 5 % reporting owner.
Administrative information
- Issuer headquarters: 1420 Presidential Drive, Richardson, TX 75081
- Reporting person address: 4500 Park Granada, Suite 202, Calabasas, CA 91302
- CUSIP: 68384X209
- Form signed by: Ryan O’Connell, Chief Operating Officer, on July 11 2025
No other transactions, financial results, or strategic actions are disclosed in this filing; its sole purpose is to update the market on Galileo Partners’ current equity position in OPXS.
Form 144 Notice of Proposed Sale filed by Optex Systems Holdings director Malhotra R. Rimmy, indicating intent to sell 15,000 shares of common stock through Fidelity Brokerage Services with an aggregate market value of $155,100.
The shares to be sold were originally acquired on April 30, 2020 as part of a stock award compensation package totaling 100,000 shares. The proposed sale represents approximately 0.22% of the company's 6,912,919 outstanding shares and is scheduled for execution on June 27, 2025 on the NASDAQ exchange.
Key details:
- No sales reported by the insider in the past 3 months
- Original acquisition was compensation-based stock award from issuer
- Filing includes standard attestation of no knowledge of undisclosed material adverse information
- Sale executed through attorney-in-fact arrangement with Fidelity Brokerage Services